Improved molecular design and immunization route of CD20 peptides induce antibody against human CD20 protein.

被引：0
|
作者：
Dao, T [1 ]
Antczak, C [1 ]
Boutsalis, G [1 ]
Kou, C [1 ]
Jaggi, J [1 ]
Kappel, B [1 ]
Pinilla-Ibarz, J [1 ]
Scheinberg, DA [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3344
引用
收藏
页码：899A / 899A
页数：1
相关论文
共 50 条
  • [1] Unique molecular recognition of CD20 by the type II CD20 antibody GA101
    Niederfellner, G. J.
    Lammens, A.
    Georges, G. J.
    Schwaiger, M.
    Franke, A.
    Wiechmann, K.
    Moessner, E.
    Umana, P.
    Hopfner, K. P.
    Klein, C.
    EJC SUPPLEMENTS, 2010, 8 (07): : 75 - 76
  • [2] Antibody against CD20 in patients with B cell malignancy
    Adamson, PJ
    Zola, H
    Nicholson, IC
    Pilkington, G
    Hohmann, A
    LEUKEMIA RESEARCH, 2001, 25 (12) : 1047 - 1050
  • [3] Development of human bispecific antibodies against CD20/CD55 or CD20/CD59 for the treatment of Burkitt lymphoma
    Macor, P.
    Secco, E.
    Mezzaroba, N.
    De Maso, L.
    Durigutto, P.
    Gaiotto, T.
    Garrovo, C.
    Biffi, F.
    Zorzet, S.
    Sblattero, D.
    Tedesco, F.
    MOLECULAR IMMUNOLOGY, 2010, 47 (13) : 2287 - 2287
  • [4] The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20
    Teeling, Jessica L.
    Mackus, Wendy J. M.
    Wiegman, Luus J. J. M.
    van den Brakel, Jeroen H. N.
    Beers, Stephen A.
    French, Ruth R.
    van Meerten, Tom
    Ebeling, Saskia
    Vink, Tom
    Slootstra, Jerry W.
    Parren, Paul W. H. I.
    Glennie, Martin J.
    van de Winkel, Jan G. J.
    JOURNAL OF IMMUNOLOGY, 2006, 177 (01): : 362 - 371
  • [5] ANALYSIS OF THE HUMAN CD20 PROMOTER
    THEVENIN, C
    KEHRL, JH
    CLINICAL RESEARCH, 1993, 41 (02): : A169 - A169
  • [6] Measuring CD20 binding for humanization of anti-CD20 antibody
    Meng, YJG
    Hong, K
    Presta, L
    Penn, A
    Adams, C
    Chuntharapai, A
    Yang, JH
    Lu, YM
    Wong, WL
    FASEB JOURNAL, 2004, 18 (04): : A59 - A59
  • [7] Characterization of a human bispecific antibody against CD20/CD55 for the treatment of burkitt lymphoma
    Macor, Paolo
    Mezzaroba, Nelly
    De Maso, Luca
    Garrovo, Chiara
    Biffi, Stefania
    Sblattero, Daniele
    Marzari, Roberto
    Tedesco, Francesco
    IMMUNOBIOLOGY, 2012, 217 (11) : 1149 - 1150
  • [8] New insights in Type I and II CD20 antibody mechanisms-of-action with a panel of novel CD20 antibodies
    Meyer, Saskia
    Evers, Mitchell
    Jansen, Johannes H. M.
    Buijs, Jos
    Broek, Blanca
    Reitsma, Stephanie E.
    Moerer, Petra
    Amini, Mojtaba
    Kretschmer, Anna
    ten Broeke, Toine
    den Hartog, Marcel T.
    Rijke, Mark
    Klein, Christian
    Valerius, Thomas
    Boross, Peter
    Leusen, Jeanette H. W.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (06) : 808 - 820
  • [9] The CD20/αCD20 ‘suicide’ system: novel vectors with improved safety and expression profiles and efficient elimination of CD20-transgenic T cells
    T van Meerten
    M-J Claessen
    A Hagenbeek
    S B Ebeling
    Gene Therapy, 2006, 13 : 789 - 797
  • [10] The CD20/αCD20 'suicide' system:: novel vectors with improved safety and expression profiles and efficient elimination of CD20-transgenic T cells
    van Meerten, T
    Claessen, MJ
    Hagenbeek, A
    Ebeling, SB
    GENE THERAPY, 2006, 13 (09) : 789 - 797
12345